AstraZeneca accused of cherry-picking vaccine study data. U.S. health officials say results from a trial of AstraZeneca’s COVID-19 vaccine may have included “outdated information” and that could mean the company provided an incomplete view of efficacy data : worldnews From “World News”

This is the best tl;dr I could make, original reduced by 85%. (I’m a bot)In an extraordinary rebuke, just hours after AstraZeneca on Monday announced its vaccine worked well in the U.S. study, an independent panel that oversees the study scolded the company for cherry-picking data, according to a senior administration official.Rebuilding confidence in its vaccine was what AstraZeneca had hoped to accomplish on Monday, when it announced that a predominantly U.S. study of 32,000 volunteers showed its vaccine was 79% effective in preventing symptomatic COVID-19 disease, and that no vaccinated volunteers had suffered severe illnesses or hospitalizations.In the AstraZeneca study, just like studies of the other vaccines in use, some participants get the real vaccine and the rest get dummy shots, and neither they nor their doctors know which is which.Extended Summary | FAQ | Feedback | Top keywords: vaccine#1 study#2 data#3 AstraZeneca#4 **U.S.**#5

Read All

Leave a Reply

Your email address will not be published. Required fields are marked *